Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FHLC vs. FTXH: which is better?

Bottom line

FHLC vs FTXH: the short answer

FHLC (Fidelity MSCI Health Care Index ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 51% by weight.

But FHLC is far broader, holding 337 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.

FHLC is cheaper at 0.084% vs 0.6% — a difference of $52 a year per $10,000 invested.

Over five years, FHLC returned +7.2% a year vs +6.5% for FTXH (reporting dates differ).

Updated Nov 19, 2026

FHLC vs FTXH side by side

FHLCFTXH
TypeETFETF
Fund familyFidelityFirst Trust
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.084%0.6%
Annual cost per $10k$8.4$60
10-yr cost on $10k (prospectus)$108—
Max front loadNoneNone
12b-1 fee0%0%
1-yr return+2.6%+24.0%
5-yr return (annualized)+7.2%+6.5%
10-yr return (annualized)+8.8%—
Best quarter+16.4%+18.3%
Worst quarter−13.1%−17.4%
Net assets (fund)$3.3B$36.2M
Number of holdings33751
Portfolio turnover3%35%
Returns as ofNov 30, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFHLCFTXHDifference
2024+2.6%+3.0%−0.4%
2023+2.5%−1.4%+3.9%
2022−5.5%+2.5%−8.0%
2021+20.4%+6.1%+14.3%
2020+18.1%+10.9%+7.3%
2019+21.9%+22.4%−0.4%
2018+5.5%−8.4%+13.9%
2017+23.3%+18.8%+4.5%

Source: Fund prospectus bar charts

Holdings overlap

11 of FHLC's top 25 holdings also appear in FTXH's top 25.

Shared top holdings
HoldingFHLCFTXH
Eli Lilly & Co13.35%7.77%
Johnson & Johnson8.93%6.96%
AbbVie Inc6.42%7.39%
Merck & Co Inc4.66%7.07%
Amgen Inc3.00%3.18%
Gilead Sciences Inc2.34%2.89%
Pfizer Inc2.06%2.97%
Bristol-Myers Squibb Co1.93%6.29%
Vertex Pharmaceuticals Inc1.76%3.41%
Regeneron Pharmaceuticals Inc1.15%2.72%
Cardinal Health Inc0.78%3.53%

Source: SEC Form N-PORT

FHLC top 10

  1. Eli Lilly & Co — 13.35%
  2. Johnson & Johnson — 8.93%
  3. AbbVie Inc — 6.42%
  4. UnitedHealth Group Inc — 5.44%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 3.09%
  7. Amgen Inc — 3.00%
  8. Abbott Laboratories — 2.66%
  9. Gilead Sciences Inc — 2.34%
  10. Pfizer Inc — 2.06%

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

FAQ

What is the difference between FHLC and FTXH?
FHLC (Fidelity MSCI Health Care Index ETF) and FTXH (First Trust Nasdaq Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 51% by weight. But FHLC is far broader, holding 337 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
Which is cheaper, FHLC or FTXH?
FHLC has the lower expense ratio (0.084%).
Should I own both FHLC and FTXH?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.